Showing results (101-110 of 178) with videos related to
Sort By:
Pageof 18
Pharmacological Research|August 27, 2019
A new dawn for managing dyslipidemias: The era of rna-based therapiesC Macchi, C R Sirtori, A Corsini, et al.Diabetes Research and Clinical Practice|April 1, 1996
Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetesS F O'Brien, G F Watts, J K Powrie, et al.Lancet (London, England)|July 30, 1994
Sex differences in endothelial function in normal and hypercholesterolaemic subjectsP J Chowienczyk, G F Watts, J R Cockcroft, et al.Diabetes, Obesity & Metabolism|July 30, 2005
Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetesR J Woodman, G F Watts, D A Playford, et al.Clinical and Experimental Pharmacology & Physiology|August 1, 1997
Determinants of the kinetics of very low-density lipoprotein apolipoprotein B-100 in non-obese menG F Watts, F M Riches, J M Kelly, et al.European Journal of Clinical Investigation|October 8, 2008
Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndromeD C Chan, G F Watts, T W K Ng, et al.Journal of Clinical Pathology|November 1, 1993
Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatinG F Watts, C Castelluccio, C Rice-Evans, et al.Circulation|September 12, 2000
Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight menT A Mori, G F Watts, V Burke, et al.Journal of Lipid Research|March 8, 2000
Genotypic associations of the hepatic secretion of VLDL apolipoprotein B-100 in obesityG F Watts, F M Riches, S E Humphries, et al.American Journal of Physiology. Endocrinology and Metabolism|August 14, 2001
Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?J C Mamo, G F Watts, P H Barrett, et al.Pageof 18